185 related articles for article (PubMed ID: 17402521)
1. Prostate cancer in Maiduguri.
Yawe KT; Tahir MB; Nggada HA
West Afr J Med; 2006; 25(4):298-300. PubMed ID: 17402521
[TBL] [Abstract][Full Text] [Related]
2. An overview of cancer of the prostate diagnosis and management in Nigeria: the experience in a Nigerian tertiary hospital.
Ajape AA; Ibrahim KO; Fakeye JA; Abiola OO
Ann Afr Med; 2010; 9(3):113-7. PubMed ID: 20710099
[TBL] [Abstract][Full Text] [Related]
3. A histopathological study of carcinoma of the prostate in Port Harcourt, Nigeria.
Obiorah CC; Nwosu SO
Niger J Clin Pract; 2011; 14(3):363-7. PubMed ID: 22037086
[TBL] [Abstract][Full Text] [Related]
4. A 6-year analysis of the clinicopathological profile of patients with prostate cancer at the University Hospital of the West Indies, Jamaica.
Coard KC; Skeete DH
BJU Int; 2009 Jun; 103(11):1482-6. PubMed ID: 19076136
[TBL] [Abstract][Full Text] [Related]
5. Male breast cancer in north eastern Nigeria.
Dogo D; Gali BM; Ali N; Nggada HA
Niger J Clin Pract; 2006 Dec; 9(2):139-41. PubMed ID: 17319346
[TBL] [Abstract][Full Text] [Related]
6. Is it necessary to detect all prostate cancers in men with serum PSA levels <3.0 ng/ml? A comparison of biopsy results of PCPT and outcome-related information from ERSPC.
Schröder FH; Bangma CH; Roobol MJ
Eur Urol; 2008 May; 53(5):901-8. PubMed ID: 18262712
[TBL] [Abstract][Full Text] [Related]
7. The frequency of benign prostate hypertrophy in Calabar.
Umezurike BI; Ekanem TB; Eluwa MA; Etta KK; Udo-Affah GA; Aligwekwe AU
Niger Postgrad Med J; 2006 Sep; 13(3):236-9. PubMed ID: 17278305
[TBL] [Abstract][Full Text] [Related]
8. Prostate cancer mortality in relation to screening by prostate-specific antigen testing and digital rectal examination: a population-based study in middle-aged men.
Agalliu I; Weiss NS; Lin DW; Stanford JL
Cancer Causes Control; 2007 Nov; 18(9):931-7. PubMed ID: 17641982
[TBL] [Abstract][Full Text] [Related]
9. Breast cancer burden in Maiduguri, North eastern Nigeria.
Nggada HA; Yawe KD; Abdulazeez J; Khalil MA
Breast J; 2008; 14(3):284-6. PubMed ID: 18476884
[TBL] [Abstract][Full Text] [Related]
10. Interval cancers in prostate cancer screening: comparing 2- and 4-year screening intervals in the European Randomized Study of Screening for Prostate Cancer, Gothenburg and Rotterdam.
Roobol MJ; Grenabo A; Schröder FH; Hugosson J
J Natl Cancer Inst; 2007 Sep; 99(17):1296-303. PubMed ID: 17728218
[TBL] [Abstract][Full Text] [Related]
11. Burden of prostate cancer in southwestern Nigeria.
Badmus TA; Adesunkanmi AR; Yusuf BM; Oseni GO; Eziyi AK; Bakare TI; Adetiloye JA; Badmus SA
Urology; 2010 Aug; 76(2):412-6. PubMed ID: 20451979
[TBL] [Abstract][Full Text] [Related]
12. Prostate cancer in Nigerians: facts and nonfacts.
Osegbe DN
J Urol; 1997 Apr; 157(4):1340-3. PubMed ID: 9120935
[TBL] [Abstract][Full Text] [Related]
13. Histopathological review of prostatic diseases in Kano, Nigeria.
Mohammed AZ; Alhassan SU; Edino ST; Ochicha O
Niger Postgrad Med J; 2003 Mar; 10(1):1-5. PubMed ID: 12717456
[TBL] [Abstract][Full Text] [Related]
14. Incidence and factors predicting the detection of prostate cancer after transurethral resection of the prostate for clinically benign disease.
Bright EA; Manuel C; Goddard JC; Khan MA
Urol Int; 2009; 83(2):171-4. PubMed ID: 19752612
[TBL] [Abstract][Full Text] [Related]
15. Role of screening in detection of clinically localized prostate cancer.
Galić J; Karner I; Cenan L; Tucak A; Vranjes Z; Bilandzija-Peranović M; Hegedus I
Coll Antropol; 2003; 27 Suppl 1():49-54. PubMed ID: 12955891
[TBL] [Abstract][Full Text] [Related]
16. PSA testing in Austria: induced morbidity and saved mortality.
Vutuc C; Waldhoer T; Lunglmayr G; Hoeltl W; Haidinger G
Eur J Cancer Prev; 2009 Sep; 18(5):377-80. PubMed ID: 19512934
[TBL] [Abstract][Full Text] [Related]
17. Baseline prostate-specific antigen level and risk of prostate cancer and prostate-specific mortality: diagnosis is dependent on the intensity of investigation.
Connolly D; Black A; Gavin A; Keane PF; Murray LJ
Cancer Epidemiol Biomarkers Prev; 2008 Feb; 17(2):271-8. PubMed ID: 18250343
[TBL] [Abstract][Full Text] [Related]
18. Hormonal predictors of prostate cancer.
Sofikerim M; Eskicorapci S; Oruç O; Ozen H
Urol Int; 2007; 79(1):13-8. PubMed ID: 17627161
[TBL] [Abstract][Full Text] [Related]
19. Obesity and oncological outcome after radical prostatectomy: impact of prostate-specific antigen-based prostate cancer screening: results from the Shared Equal Access Regional Cancer Hospital and Duke Prostate Center databases.
Freedland SJ; Sun L; Kane CJ; Presti JC; Terris MK; Amling CL; Moul JW; Aronson WJ
BJU Int; 2008 Sep; 102(8):969-74. PubMed ID: 18691175
[TBL] [Abstract][Full Text] [Related]
20. Changes in case mix and treatment patterns in prostate cancer in Saskatchewan during the prostate specific antigen testing era.
Tonita JM; Skarsgard D; Muhajarine N
Cancer Causes Control; 2009 Mar; 20(2):201-9. PubMed ID: 18825504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
